Latest News
Featured News
Preliminary Results for the Year Ended 30 April 2025
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
Issue of share options
Scancell to present translational data from the Phase 2 ongoing SCOPE trial of SCIB1 at the 2025 AACR IO conference
Interim Results for the six months ended 31 October 2024
Notice of Interim Results
Scancell’s Modi-1 Moditope Vaccine Achieves Early Clinical Validation in Head and Neck Cancer
Scancell announces Genmab exercises option to a second commercial license agreement
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.